Month: November 2021

Nov 13 2021

Uncategorized

Schizophrenia burden totaled more than $340 billion in 2019

by Clinical Editor

No Comments

Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.Adjusted for inflation, this represented a 99.8% increase in …

Nov 13 2021

Uncategorized

Cigarette Smoking and Life Expectancy in Schizophrenia

by Clinical Editor

No Comments

Put out your cigarette. Researchers performed a cohort study of the impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder, and bipolar disorder.

Nov 13 2021

Uncategorized

Antipsychotic Patch Quiets Schizophrenia-Related Hostility

by Clinical Editor

No Comments

The antipsychotic “patch” effectively reduced hostility among patients with schizophrenia, a researcher reported. In a post-hoc analysis of a phase III trial, once-daily asenapine transdermal system …

Nov 12 2021

Uncategorized

Schizophrenia: A Difference of Kind

by Clinical Editor

No Comments

I wish here to provide a brief refutation of this notion and an examination of schizophrenia as a pathology that differs in kind from normal human experience. For these and...

Nov 12 2021

Uncategorized

Antipsychotics and New-Onset Obsessive-Compulsive Disorder in Schizophrenia

by Clinical Editor

No Comments

Comorbidity or medication adverse effect? Researchers performed a nested case-control study of new-onset obsessive-compulsive disorder following antipsychotic use in schizophrenia.

Nov 12 2021

Uncategorized

Schizophrenia drug landscape: a stagnant field on the cusp of change?

by Clinical Editor

No Comments

Several pipeline therapies could shake up the schizophrenia field, but their road through development is unlikely to be an easy path. Most new drugs in schizophrenia have relied on similar...

Nov 12 2021

Uncategorized

Schizophrenia burden totaled more than $340 billion in 2019

by Clinical Editor

No Comments

Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.Adjusted for inflation, this represented a 99.8% increase in …

Nov 12 2021

Uncategorized

Psychosocial interventions can help prevent schizophrenia relapse

by Clinical Editor

No Comments

(HealthDay)—Psychosocial and psychological interventions are effective for relapse prevention in schizophrenia, according to a review published online Oct. 12 in The Lancet Psychiatry.

Nov 11 2021

Uncategorized

Schizophrenia: A Difference of Kind – Psychiatric Times

by Clinical Editor

No Comments

Schizophrenia: A Difference of Kind  Psychiatric Times

Nov 11 2021

Uncategorized

Schizophrenia: A Difference of Kind

by Clinical Editor

No Comments

I wish here to provide a brief refutation of this notion and an examination of schizophrenia as a pathology that differs in kind from normal human experience. For these and...